Literature DB >> 16898178

Use of proteomics in analysis of autoimmune diseases.

Y Xiang1, T Kato.   

Abstract

Autoimmune diseases are common by diseases characterized by disorders of immune responses and autoimmune impairment involving multiple tissues, organs and systems. The autoantigens (Ags)/autoantibodies (Abs) are not only hallmarks but also involved in pathogenesis of autoimmune diseases. In recent years, proteomics technologies have been used and demonstrated effective in searching new Ags/Abs as well as disease biomarkers in autoimmune diseases.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16898178     DOI： 10.1191/0961203306lu2329oa

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


  3 in total

1.  Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome.

Authors:  Motohisa Yamamoto; Yasuyoshi Naishiro; Chisako Suzuki; Yasuo Kokai; Ryo Suzuki; Saho Honda; Takashi Abe; Hiroki Takahashi; Yasuhisa Shinomura
Journal:  Rheumatol Int       Date:  2009-07-17       Impact factor: 2.631

2.  Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome.

Authors:  Xiao-Li Wang; Qiang Chai; M Cristine Charlesworth; Juan J Figueroa; Phillip Low; Win-Kuang Shen; Hon-Chi Lee
Journal:  Proteomics Clin Appl       Date:  2012-11-08       Impact factor: 3.494

3.  A comparative proteomic study of sera in paediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS-A pilot study.

Authors:  Anita Rana; Ranjana W Minz; Ritu Aggarwal; Sadhna Sharma; Neelam Pasricha; Shashi Anand; Surjit Singh
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-17       Impact factor: 3.054
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.